Delinquencies in subprime auto loans are on the rise, and that could signal bad news for lenders and automakers.
A committee for drugmaker Mylan has donated in the past to most of the Senate committee that has asked it to explain price hikes.
Bond guru Bill Gross tells CNBC he's disappointed that the Fed may consider buying other asset classes if there's another recession.
Fed Chair Janet Yellen signaled a rate hike could be coming this year, and markets stuck to the view that the most likely time is December.
If you're on an iPhone, there's something you need to know.
Neither Trump nor Clinton are really connecting with female voters. You know what they need to do? Watch the hit movie "Bad Moms," says Jake Novak.
Leon Black's private-equity firm is taking Rackspace private as the cloud-computing company has struggled against tech heavyweights.
According to Wall Street Journal, former MLB player Jose Canseco is Twitter's favorite financial analyst. CNBC's Brian Sullivan discusses why.
On Friday, St. Jude refuted Muddy Waters' claims, saying that the "report is false and misleading."
Whether it’s celebrity investors or small businesses on Main Streets across America, these are the stories of the entrepreneurial heroes behind the movement
Federal officials say the government will make a $2.45 billion loan to Amtrak to buy new trains.
Bill Ackman tells CNBC the past 12 months were the "worst period of performance" of his career, and the implosion of Valeant Pharmaceuticals was mostly to blame.
Taxpayers who attest to honestly missing the IRS' 60-day limit for tax-free 401(k) and IRA rollovers can now qualify for a waiver.
Investors should buy Amazon on the prospect of it entering the massive autos market, according to Morgan Stanley.
Richard Branson says he thought he was going to die after flying head first off his bicycle in the British Virgin Islands.
Viacom also affirmed its support for Brad Grey as head of Paramount Pictures movie studio in a statement Friday.
Bill Ackman tells CNBC he was approached indirectly by Carl Icahn to purchase a stake in Herbalife — his longtime short target.
Here's a look at some of the reported downsides facing people who take binge watching too far.
The FDA and Congress enabled Mylan to secure a monopoly on EpiPens and then jack up the prices, says this intellectual-property expert. So why can't they just end it?